Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3990523 | Journal of Thoracic Oncology | 2012 | 10 Pages |
Abstract
Long-term, prediagnostic NSAID use does not improve lung cancer survival overall. Use of ibuprofen may reduce survival from lung cancer. Our results underscore the need for further study of the mechanisms of action for individual NSAIDs with regard to cancer survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Theodore M. PhD, Christina S. MD, Christopher G. MD, Mariela MPH, Emily PhD,